Employment |
No Relationships to Disclose |
|
|
Leadership |
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests |
No Relationships to Disclose |
|
|
Honoraria |
No Relationships to Disclose |
|
|
Consulting or Advisory Role |
Company: Genentech |
Recipient: You |
Company: Lilly |
Recipient: You |
Company: Celgene |
Recipient: You |
Company: Merck |
Recipient: You |
Company: Astra Zeneca |
Recipient: You |
Company: Blueprint Genetics |
Recipient: You |
Company: Shionogi |
Recipient: You |
Company: Daiichi Sankyo/Astra Zeneca |
Recipient: You |
Company: Regeneron/ Sanofi |
Recipient: You |
Company: Eisai |
Recipient: You |
Company: BeiGene |
Recipient: You |
Company: Turning Point Therapeutics |
Recipient: You |
Company: Pfizer |
Recipient: You |
Company: Janssen |
Recipient: You |
Company: Boehringer Ingelheim |
Recipient: You |
|
Speakers' Bureau |
Company: AstraZeneca |
Recipient: An Immediate Family Member |
Company: Roche/Genentech |
Recipient: An Immediate Family Member |
|
Research Funding |
Company: Genentech/Roche |
Recipient: Your Institution |
Company: Incyte |
Recipient: Your Institution |
Company: Macrogenics |
Recipient: Your Institution |
Company: Merck Sharp & Dohme |
Recipient: Your Institution |
Company: AstraZeneca/MedImmune |
Recipient: Your Institution |
|
Patents, Royalties, Other Intellectual Property |
No Relationships to Disclose |
|
|
Expert Testimony |
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses |
No Relationships to Disclose |
|
|
Other Relationship |
No Relationships to Disclose |
|
|
(OPTIONAL) Uncompensated Relationships |
No Relationships to Disclose |
|
|
(OPTIONAL) Open Payments Link |
No Relationships to Disclose |
|
|